Dr. Martens plc (DRMTY)

OTCMKTS · Delayed Price · Currency is USD
1.580
0.00 (0.00%)
At close: May 30, 2025
-29.43%
Market Cap 989.35M
Revenue (ttm) 1.02B
Net Income (ttm) 5.81M
Shares Out n/a
EPS (ttm) n/a
PE Ratio 170.17
Forward PE 17.20
Dividend 0.04 (2.58%)
Ex-Dividend Date Mar 7, 2025
Volume 100
Average Volume 946
Open 1.580
Previous Close n/a
Day's Range 1.580 - 1.580
52-Week Range 0.780 - 2.120
Beta 0.15
RSI 51.08
Earnings Date Jun 5, 2025

About Dr. Martens

Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear under the Dr. Martens brand name in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company was founded in 1945 and is based in London, the United Kingdom. [Read more]

Founded 1945
Employees 2,630
Stock Exchange OTCMKTS
Ticker Symbol DRMTY
Full Company Profile

Financial Performance

In 2024, Dr. Martens's revenue was 787.60 million, a decrease of -10.20% compared to the previous year's 877.10 million. Earnings were 4.50 million, a decrease of -93.50%.

Financial numbers in GBP Financial Statements

News

New Dr Martens boss plans revival by focusing on shoes and sandals as well as boots

Ije Nwokorie (pictured), who took over this year, said the 'narrow focus on boots failed to take full advantage' of other areas of the business.

1 day ago - This is Money

Dr Martens sees profits slide but on track for return to growth

The footwear group reported pre-tax profits of £8.8 million for the year to March 30, down from £93 million the previous year.

1 day ago - Evening Standard

Dr Martens forecasts return to profit growth, shares jump

British bootmaker Dr Martens forecast a return to profit growth in the current financial year on Thursday, backed by its new CEO's plan to put more emphasis on shoes, sandals, and bags, as well as the...

1 day ago - Reuters

Botched expansion puts the boot into Dr Martens

The FTSE 250 firm is predicted to report a pre-tax profit of £28 million for the year to March 31, 2025, 69 per cent down on a year ago.

6 days ago - This is Money

Companies Reporting: Pennon, BAT, B&M, Fevertree, Dr Martens

Pennon, BAT, B&M, Fevertree, Dr Martens are amongst the FTSE 350 and other companies reporting earnings for the week of 02 June

8 days ago - The Armchair Trader

Dr. Martens Selects Amperity to Transform Customer Data Strategy

LONDON--(BUSINESS WIRE)-- #AdTech--Amperity, an AI-powered customer data cloud, today announced Dr. Martens, an iconic British brand, has selected its platform to support its global data and marketing...

3 months ago - Business Wire

UK Stock Market News: Johnson Matthey, Dr Martens, Ryanair

Can Johnson Matthey placate activist investors? Q3 numbers show Dr Martens remains big in Japan, Ryanair update shows strong Christmas

4 months ago - The Armchair Trader

'Welsh, fat and working-class is my superpower'

Over the past few years Megan Winstone has taken photographs for Vogue, Kerrang! and Dr. Martens.

5 months ago - BBC

Half Year 2025 Dr Martens PLC Earnings Call Transcript

Half Year 2025 Dr Martens PLC Earnings Call Transcript

6 months ago - GuruFocus

Dr Martens boosted by good start to Christmas trading

Departing chief says bootmaker has started to stabilise after several profit warnings and poor performance in the US

6 months ago - Financial Times

Dr Martens’ shares jump 15% on new CEO’s start date despite drop in first half sales

Dr Martens said its new CEO Ije Nwokorie will take over from incumbent Kenny Wilson on Jan. 6 2025, in a shakeup investors hope could boost the struggling boot maker

6 months ago - MarketWatch

Dr Martens Surges as Sales Rise and US Shows Signs of Recovery

Dr Martens Plc shares soared after the footwear company reported a better-than-expected interim performance and said it’s on track to meet targets unveiled earlier this year.

6 months ago - BNN Bloomberg

Dr Martens swings to loss and braces for currency hit

The bootmaker reported pre-tax losses of £28.7 million for the six months to September 29 against profits of £25.8 million the previous year.

6 months ago - Evening Standard

Three Quick Facts: Direct Line, Loungers, Dr Martens

Aviva’s approach for Direct Line confirmed – and rejected, Loungers set to fold to private equity bid, headwinds persist at Dr Martens

6 months ago - The Armchair Trader

Dr Martens sees strong US holiday sales, cuts inventory and debt

Dr Martens said on Thursday that the autumn-winter festive season had got off to an encouraging start and investors welcomed a reduction in net debt as the bootmaker tries to turn its performance arou...

6 months ago - Reuters

Stock Picks From Seeking Alpha's October 2024 New Analysts

In October, 42 new analysts joined Seeking Alpha, sharing diverse investment ideas and strategies, from biotech to real estate. Highlighted strong buy recommendations include MicroStrategy, CorMedix, ...

7 months ago - Seeking Alpha

Dr Martens shares slump: should you give it the boot?

Over the past three years, Dr Martens has fallen out of fashion. Are the shares worth a look?

9 months ago - MoneyWeek